Effect of synthetic thyrotrophin-releasing factor on pituitary TSH secretion in normal subjects and patients with hypothalamic-pituitary disorders.
D000238:Adenoma, Chromophobe / Q000378:metabolism*; D000293:Adolescent; D000328:Adult; D000368:Aged; D003397:Craniopharyngioma / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007018:Hypopituitarism / Q000378:metabolism*; D007456:Iodine Isotopes; D008297:Male; D008579:Meningioma / Q000378:metabolism; D008875:Middle Aged; D010871:Pinealoma / Q000378:metabolism*; D010902:Pituitary Gland / Q000187:drug effects / Q000378:metabolism*; D011863:Radioimmunoassay; D013972:Thyrotropin / Q000097:blood / Q000378:metabolism*; D013973:Thyrotropin-Releasing Hormone / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D013974:Thyroxine / Q000097:blood / Q000378:metabolism
D007456:Iodine Isotopes; D013973:Thyrotropin-Releasing Hormone; D013972:Thyrotropin; D013974:Thyroxine